We uphold the value of “innovation” Many of our technologies have won the recognitions of “Innovative Medical Device” in China
We own the intellectual property rights of our technologies in the world.
Develop strategically the treatments of many indications such as atrial fibrillation, hypertension, respiratory, urinary, digestive, and other diseases in the areas of vascular intervention and NOTES.
The company has built up the foundational and core material technologies, and a strong team of highly demanded technical talents and leaders with rich management experience. Such strength provides competitive advantages in core technology expansion, scaleup production, sales partnership, tendering and other commercial operations.
Our core cryoablation technology encompass high entrant barriers，which is a safe, user-friendly treatment modality with satisfactory clinical outcomes, that ablates abnormal or diseased tissue by extreme low temperature.